Six-month effects of modified Atkins diet implementation on indices of cardiovascular disease risk in adults with epilepsy

References

• Zupec-Kania BA, Spellman E. An overview of the ketogenic diet for pediatric epilepsy. Nutr Clin Pract. 1998;23(6):589–96.
   Google Scholar
• Kossoff EH, Rowley H, Sinha SR, Vining EPG. A prospective study of the modified Atkins diet for intractable epilepsy in adults. Epilepsia. 2008;49(2):316–19.
   PubMed Web of Science ®Google Scholar
• Klein P, Tyrlikova I, Mathews GC. Dietary treatment in adults with refractory epilepsy: a review. Neurology [Internet]. 2014;83(21):1978–85. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25355830.
   PubMed Web of Science ®Google Scholar
• Cervenka MC, Henry BJ, Felton EA, Patton K, Kossoff EH. Establishing an adult epilepsy diet center: experience, efficacy and challenges. Epilepsy Behav. 2016;58:61–68. doi:https://doi.org/10.1016/j.yebeh.2016.02.038.
   PubMed Web of Science ®Google Scholar
• Dashti HM, Al-Zaid NS, Mathew TC, Al-Mousawi M, Talib H, Asfar SK, et al. Long term effects of ketogenic diet in obese subjects with high cholesterol level. Mol Cell Biochem. 2006;286(1–2):1–9.
   PubMed Web of Science ®Google Scholar
• Volek JS, Phinney SD, Forsythe CE, Quann EE, Wood RJ, Puglisi MJ, et al. Carbohydrate restriction has a more favorable impact on the metabolic syndrome than a low fat diet. Lipids. 2009;44(4):297–309.
   PubMed Web of Science ®Google Scholar
• Paoli A, Rubini A, Volek JS, Grimaldi KA. Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets. Eur J Clin Nutr. 2013;67(8):789–96. doi:https://doi.org/10.1038/ejcn.2013.116.
   PubMed Web of Science ®Google Scholar
• Walldius G, Jungner I. Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy. Eur Heart J. 2005;26(3):210–12.
   PubMed Web of Science ®Google Scholar
• Santos FL, Esteves SS, da Costa Pereira A, Yancy WS, Nunes JPL. Systematic review and meta-analysis of clinical trials of the effects of low carbohydrate diets on cardiovascular risk factors. Obes Rev. 2012;13(11):1048–66.
   PubMed Web of Science ®Google Scholar
• Hu T, Mills KT, Yao L, Demanelis K, Eloustaz M, Yancy WS. Effects of low-carbohydrate diets versus low-fat diets on metabolic risk factors: a meta-analysis of randomized controlled clinical trials. Am J Epidemiol. 2012;176:S44–S54.
   PubMed Web of Science ®Google Scholar
• Bhanpuri NH, Hallberg SJ, Williams PT, McKenzie AL, Ballard KD, Campbell WW, et al. Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: An open label, non-randomized, controlled study. Cardiovasc Diabetol. 2018;17(1):1–16. doi:https://doi.org/10.1186/s12933-018-0698-8.
   PubMedGoogle Scholar
• Gershuni VM, Yan SL, Medici V. Nutritional ketosis for weight management and reversal of metabolic syndrome. Curr Nutr Rep. 2018;7(3):97–106.
   PubMedGoogle Scholar
• Cervenka MC, Patton K, Eloyan A, Henry B, Kossoff EH. The impact of the modified Atkins diet on lipid profiles in adults with epilepsy. Nutr Neurosci. 2016;19(3):131–37. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L609460799%5Cnhttps://doi.org/https://doi.org/10.1179/1476830514Y.0000000162.
   PubMed Web of Science ®Google Scholar
• Zare M, Okhovat AA, Esmaillzadeh A, Mehvari J, Najafi MR, Saadatnia M. Modified atkins diet in adult patients with refractory epilepsy: a controlled randomized clinical trial. Iran J Neurol. 2017;16(2):72–77. Available from: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed17&NEWS=N&AN=72155838.
   PubMed Web of Science ®Google Scholar
• Kverneland M, Molteberg E, Iversen PO, Veierød MB, Taubøll E, Selmer KK, et al. Effect of modified Atkins diet in adults with drug-resistant focal epilepsy: a randomized clinical trial. Epilepsia. 2018;59:1567–76.
   PubMed Web of Science ®Google Scholar
• Mcdonald TJW, Henry-Barron BJ, Felton EA, Gutierrez EG, Barnett J, Fisher R, et al. Improving compliance in adults with epilepsy on a modified Atkins diet: a randomized trial. Seizure Eur J Epilepsy. 2018;60:132–38.
   PubMed Web of Science ®Google Scholar
• McDonald TJW, Ratchford EV, Henry-Barron BJ, Kossoff EH, Cervenka MC. Impact of the modified Atkins diet on cardiovascular health in adults with epilepsy. Epilepsy Behav. 2018;79:82–86.
   PubMed Web of Science ®Google Scholar
• Durnin JVGA, Womersley J. Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years. Br J Nutr [Internet]. 1973;32(1):77–97. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4843734.
   Web of Science ®Google Scholar
• Caulfield MP, Li S, Lee G, Blanche PJ, Salameh WA, Benner WH, et al. Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem. 2008;54(8):1307–16.
   PubMed Web of Science ®Google Scholar
• Ye F, Li XJ, Jiang WL, Bin SH, Liu J. Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis. J Clin Neurol. 2015;11(1):26–31.
   PubMed Web of Science ®Google Scholar
• Chuang Y-C, Chuang H-Y, Lin T-K, Chang C-C, Lu C-H, Chang W-N, et al. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis. Epilepsia [Internet]. 2012;53(1):120–28. Available from: http://doi.wiley.com/10. 1111/j.1528-1167.2011.03316.x.
   PubMed Web of Science ®Google Scholar
• de Souza Neves G, dos Santos Lunardi M, Papini Gabiatti M, Kurrle Rieger Venske D, Ribeiro LC, Lin K, et al. Cardiometabolic risk and effectiveness of the modified Atkins ketogenic diet for adult patients with pharmacoresistant epilepsies in a middle-income country. Epilepsy Res. 2020;160(January):106280. doi:https://doi.org/10.1016/j.eplepsyres.2020.106280.
   PubMedGoogle Scholar
• Smith M, Politzer N, MacGarvie D, McAndrews MP, Del Campo M. Efficacy and tolerability of the modified Atkins diet in adults with pharmacoresistant epilepsy: a prospective observational study. Epilepsia. 2011;52(4):775–80.
   PubMed Web of Science ®Google Scholar
• Mudd JO, Borlaug BA, Johnston PV, Kral BG, Rouf R, Blumenthal RS, et al. Beyond low-density lipoprotein cholesterol. Defining the role of low-density lipoprotein heterogeneity in Coronary artery disease. J Am Coll Cardiol. 2007;50(18):1735–41.
   PubMed Web of Science ®Google Scholar
• Superko HR, Gadesam RR. Is it LDL particle size or number that correlates with risk for cardiovascular disease? Curr Atheroscler Rep. 2008;10:377–85.
   PubMed Web of Science ®Google Scholar